PHAT
Phathom Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$7.48
−3.48%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 9.64x
- P/E 2028E
- 3.52x
- P/S forward
- 1.53x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -1.76x
- Price / sales
- 2.52x
- Price / cash flow
- -16.49x
Enterprise value
- Enterprise value
- $589.8M
- EV / sales
- 2.46x
- EV / EBITDA
- -16.78x
- EV / EBIT
- -14.51x
- Market cap
- $605.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026